Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Olaparib Tablets

Approval Number

国药准字H20243822

Company南京方生和医药科技有限公司

Registration Date

May 28, 2024

Drug Information

Generic Name

奥拉帕利片

Dosage Form

片剂

Strength

150mg

Drug Type

化学药品

Registration Date

May 28, 2024

Company Information

Applicant Company

Company Name南京方生和医药科技有限公司

Company Address

南京市浦口区浦口经济开发区百合路111号紫峰研创中心一期2栋

Manufacturing Company

Company Name江苏利泰尔药业有限公司

Company Address

南京市江宁区盛运路6号（江宁开发区）

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy